Arpida Raises CHF51.3M, Plans To Move Iclaprim Into Phase III Published: May 12, 2004 Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. Related links BioWorld International This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news